Byetta Clinical Trials Byetta RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Effectiveness of Once-weekly Exenatide (BCise) Plus Dapagliflozin on 24 Hour Glucose Variability Measured by CGM. A Proof of Concept.
Condition:   Change in Baseline Amplitude of Glucose Excursions Interventions:   Drug: Exenatide 2 MG;   Drug: Dapagliflozin 10 MG Sponsor:   Consano Clinical Research, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 31, 2019 Category: Research Source Type: clinical trials

Effectiveness of Exenatide Plus Dapagliflozin on 24 Hour Glucose Variability Measured by CGM. A Proof of Concept.
Condition:   Diabetes Mellitus, Type 2 Interventions:   Drug: Exenatide 2 MG;   Drug: Dapagliflozin 10 MG Sponsor:   Consano Clinical Research, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 31, 2019 Category: Research Source Type: clinical trials